2003 FASEB Summer Conference on Lysophospholipids
2003 年 FASEB 溶血磷脂夏季会议
基本信息
- 批准号:6597284
- 负责人:
- 金额:$ 0.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2004-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This application requests partial funding for a conference entitled "Lysolphospholipids and Related Lipids in Biology and Diseases" which will be held at the Snowmass Conference Center (Snowmass, Colorado) between June 28-July 3, 2003 under the auspices of FASEB. This conference is a continuation of a previous conference held in 2000 that had a major impact on this rapidly developing field and was rated excellent by the attendees. There are no other theme conferences on the topic. Because it is the only international theme meeting on this subject, it fills an important need for the development of the field. Lysolphospholipids, including lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), are lipid mediators with growth factor-like actions that are emerging targets of drug discovery due to their involvement in the pathologies of cardiovascular (angiogenesis, heart development, atherosclerosis), (auto)immune diseases and cancer. The protean roles of LPA, S1P, and related lipids include mediation of cellular proliferation, differentiation, survival, and malignant transformation. Since the last conference, four articles appeared in Science magazine and three in Nature reporting on discoveries related to these lysophospholipids. The conference will present a contemporary view of molecular biological, biochemical, and (patho)physiological mechanisms of action of lysophospholipids as well as their synthesis and metabolic inactivation with a focus on therapeutic correlations. Approximately 150 participants will be chosen. Invited speakers will be persons with significant recent achievements. A novel aspect of the conference will be a special round table discussion about future trends and cooperation among investigators with different backgrounds entering the field. Participation of women and minorities will be vigorously solicited and travel awards for 8 junior scientist (students and post docs) will be sought. There will be sessions focused on 1) Enzymatic mechanisms generating these mediators, 2) Lipid phosphate phosphatases, 3) LPA and S1P receptors, 4) Signal transduction, 5) Lysolipid regulation of the immune response, 6) Lysolipids in vascular biology, and 7) Lysolipids in the diagnosis and management of cancer. The conference should provide a contemporary perspective of this rapidly moving field and allow the evaluation of future directions, as well as critical review of recent research.
描述(由申请人提供):本申请要求为题为“生物学和疾病中的溶血磷脂和相关脂质”的会议提供部分资金,该会议将在FASEB的赞助下于2003年6月28日至7月3日在斯诺马斯会议中心(斯诺马斯,科罗拉多)举行。本次会议是2000年举办的上一次会议的延续,该会议对这一迅速发展的领域产生了重大影响,并被与会者评为优秀。没有关于该主题的其他主题会议。由于它是关于这一主题的唯一国际专题会议,它满足了这一领域发展的重要需要。溶血磷脂,包括溶血磷脂酸(LPA)和1-磷酸鞘氨醇(S1 P),是具有生长因子样作用的脂质介质,由于它们参与心血管(血管生成、心脏发育、动脉粥样硬化)、(自身)免疫疾病和癌症的病理,它们是药物发现的新兴靶点。LPA、S1 P和相关脂质的多种作用包括介导细胞增殖、分化、存活和恶性转化。自上次会议以来,四篇文章出现在科学杂志和三个自然报告有关这些溶血磷脂的发现。会议将介绍溶血磷脂作用的分子生物学,生物化学和(病理)生理机制的当代观点,以及它们的合成和代谢失活,重点是治疗相关性。将选出约150名参与者。特邀演讲者将是最近取得重大成就的人。会议的一个新的方面将是一个特别的圆桌会议讨论未来的趋势和不同背景的调查人员之间的合作进入该领域。将积极争取妇女和少数民族的参与,并为8名青年科学家(学生和博士后)争取旅行奖。将有会议集中在1)产生这些介质的酶机制,2)脂质磷酸磷酸酶,3)LPA和S1 P受体,4)信号转导,5)免疫反应的溶脂调节,6)血管生物学中的溶脂,和7)溶脂在癌症的诊断和管理。会议应提供这一快速发展领域的当代视角,并允许对未来方向进行评估,以及对最近研究的批判性审查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GABOR J TIGYI其他文献
GABOR J TIGYI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GABOR J TIGYI', 18)}}的其他基金
IND-enabling development of Radioprotectin 1: a dual GI/HE radiation mitigator
Radioprotectin 1 的 IND 开发:双重 GI/HE 辐射缓解剂
- 批准号:
10794519 - 财政年份:2023
- 资助金额:
$ 0.2万 - 项目类别:
Radiobiology Research Suite Expansion of the TriMetis GLP Vivarium at UTHSC
UTHSC 的 TriMetis GLP Vivarium 放射生物学研究套件扩建
- 批准号:
10374310 - 财政年份:2021
- 资助金额:
$ 0.2万 - 项目类别:
IND-enabling development of Radioprotectin 1: a dual GI/HE radiation mitigator
Radioprotectin 1 的 IND 开发:双重 GI/HE 辐射缓解剂
- 批准号:
10401460 - 财政年份:2020
- 资助金额:
$ 0.2万 - 项目类别:
IND-enabling development of Radioprotectin 1: a dual GI/HE radiation mitigator
Radioprotectin 1 的 IND 开发:双重 GI/HE 辐射缓解剂
- 批准号:
10845827 - 财政年份:2020
- 资助金额:
$ 0.2万 - 项目类别:
IND-enabling development of Radioprotectin 1: a dual GI/HE radiation mitigator
Radioprotectin 1 的 IND 开发:双重 GI/HE 辐射缓解剂
- 批准号:
10194368 - 财政年份:2020
- 资助金额:
$ 0.2万 - 项目类别:
IND-Enabling Preclinical Development of a New Radiomitigator
IND 促进新型放射缓解剂的临床前开发
- 批准号:
9280853 - 财政年份:2013
- 资助金额:
$ 0.2万 - 项目类别:
IND-Enabling Preclinical Development of a New Radiomitigator
IND 促进新型放射缓解剂的临床前开发
- 批准号:
9064077 - 财政年份:2013
- 资助金额:
$ 0.2万 - 项目类别:
IND-Enabling Preclinical Development of a New Radiomitigator
IND 促进新型放射缓解剂的临床前开发
- 批准号:
8842923 - 财政年份:2013
- 资助金额:
$ 0.2万 - 项目类别:
Novel Radiomitigators Targeting LPA Receptors
针对 LPA 受体的新型放射缓解剂
- 批准号:
8760294 - 财政年份:2012
- 资助金额:
$ 0.2万 - 项目类别:














{{item.name}}会员




